DE3480400D1 - Islets-activating protein derivatives - Google Patents

Islets-activating protein derivatives

Info

Publication number
DE3480400D1
DE3480400D1 DE8484303169T DE3480400T DE3480400D1 DE 3480400 D1 DE3480400 D1 DE 3480400D1 DE 8484303169 T DE8484303169 T DE 8484303169T DE 3480400 T DE3480400 T DE 3480400T DE 3480400 D1 DE3480400 D1 DE 3480400D1
Authority
DE
Germany
Prior art keywords
islets
activating protein
protein derivatives
derivatives
activating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8484303169T
Other languages
English (en)
Inventor
Katsumi Nogimori
Makoto Tamura
Shigeki Kurokawa
Motoyuki Yajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3480400D1 publication Critical patent/DE3480400D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8484303169T 1983-05-11 1984-05-10 Islets-activating protein derivatives Expired DE3480400D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58082363A JPS59206316A (ja) 1983-05-11 1983-05-11 インシユリン分泌増強活性物質誘導体およびその製法

Publications (1)

Publication Number Publication Date
DE3480400D1 true DE3480400D1 (en) 1989-12-14

Family

ID=13772492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484303169T Expired DE3480400D1 (en) 1983-05-11 1984-05-10 Islets-activating protein derivatives

Country Status (4)

Country Link
US (1) US4609549A (de)
EP (1) EP0125892B1 (de)
JP (1) JPS59206316A (de)
DE (1) DE3480400D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
US4791192A (en) * 1986-06-26 1988-12-13 Takeda Chemical Industries, Ltd. Chemically modified protein with polyethyleneglycol
DE102008000161A1 (de) 2007-01-26 2008-07-31 Sachtleben Chemie Gmbh Verfahren zur Vermeidung störender Schwefelwasserstoffbildung in Biogasanlagen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2227861B1 (de) * 1973-05-04 1976-07-02 Anvar
JPS5396392A (en) * 1977-02-01 1978-08-23 Kakenyaku Kako Kk Active substance for increasing secretion of insulin
JPS6019733B2 (ja) * 1977-06-10 1985-05-17 科研製薬株式会社 蛋白質性活性物質
JPS55129295A (en) * 1979-03-27 1980-10-06 Kaken Pharmaceut Co Ltd Amidino derivative of insulin secretion stimulating substance
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid

Also Published As

Publication number Publication date
JPS59206316A (ja) 1984-11-22
US4609549A (en) 1986-09-02
EP0125892A3 (en) 1986-01-15
EP0125892B1 (de) 1989-11-08
EP0125892A2 (de) 1984-11-21

Similar Documents

Publication Publication Date Title
GB8334499D0 (en) Derivatives
GB8405980D0 (en) N-pyridylpyrazole derivatives
EP0135177A3 (en) Benzocycloalkane derivatives
EP0129513A3 (en) Oxamic-acid derivatives
GB2145084B (en) Fredericamycin derivatives
GB8416172D0 (en) Spirosuccinide derivatives
GB8427363D0 (en) Oxabicycloheptane derivatives
GB8415032D0 (en) 3-phenyl-4-cyano-pyrrole derivatives
DE3475621D1 (en) 2-dioxacycloalkylthiopenem derivatives
DE3479730D1 (en) Fluoromethylthiooxacephalosporin derivatives
GR80371B (en) 3-indolecarboxamide derivatives
GB2146991B (en) Fluorenylalkylimidazole derivatives
EG16589A (en) 2-azacycloalkylthiopenem derivatives
GR80634B (en) 2-azacycloalkylthiopenem derivatives
GB2152046B (en) 2-arylbenzothiazoline derivatives
DE3460649D1 (en) Cyanotercyclohexane derivatives
AR243155A1 (es) Procedimiento para la preparacion de nuevas benzamidas n-aminoetil-sustituidas.
GB8408128D0 (en) Gonadoliberine derivatives
DE3480400D1 (en) Islets-activating protein derivatives
GR80515B (en) Fluoralkylatedcarbapenem derivatives
EP0143001A3 (en) Pyrimidoisoquinoline derivatives
GR80582B (en) Azolyl-tetrahydrofuran-2-yliden-methan derivatives
GR82491B (en) Iminomethyl - azolyl derivatives
GR80442B (en) Triazolylmethyl-pyridyloxymethyl-carbinol derivatives
GB8420270D0 (en) Derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee